Evidence is inadequate to reliably conclude that early detection of skin cancer through
visual skin examination by a clinician reduces morbidity or mortality.
«Evidence insufficient to make recommendation regarding
visual skin examination by a clinician.»
Evidence is adequate that
visual skin examination by a clinician to screen for skin cancer leads to harms that are at least small, but current data are insufficient to precisely bound the upper magnitude of these harms.
Evidence is more limited and inconsistent regarding the accuracy of the clinical
visual skin examination for detecting nonmelanoma skin cancer.
The U.S. Preventive Services Task Force (USPSTF) has concluded that the current evidence is insufficient to assess the balance of benefits and harms of
visual skin examination by a clinician to screen for skin cancer in asymptomatic adults.
Not exact matches
It is therefore unknown whether there is an incremental benefit to detecting nonmelanoma
skin cancer through a program of regular
visual clinical
examination vs patient self - identification as part of general body awareness followed by reasonably prompt evaluation by a clinician.
Diagnosis is made by
visual observation of the symptoms and microscopic
examination of
skin scrapings.